Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-08-24 FOEHR MATTHEW W President and COO Option exercise +78 $21.92 $2K 155,491
2020-08-24 FOEHR MATTHEW W President and COO Sale −78 $110.89 $9K 155,413
2020-08-24 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −78 64,547
2020-08-21 FOEHR MATTHEW W President and COO Option exercise +790 $74.42 $59K 155,413
2020-08-21 FOEHR MATTHEW W President and COO Option exercise +7,225 $14.47 $105K 162,638
2020-08-21 FOEHR MATTHEW W President and COO Sale −7,225 $112.88 $816K 155,413
2020-08-21 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −7,225 0
2020-08-21 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −790 64,210
2020-07-07 HIGGINS JOHN L Chief Executive Officer Option exercise +1,165 $85.79 $100K 201,421
2020-07-07 HIGGINS JOHN L Chief Executive Officer Option exercise +1,777 $56.26 $100K 203,198
2020-07-07 HIGGINS JOHN L Chief Executive Officer Option exercise +1,373 $74.42 $102K 204,571
2020-07-07 HIGGINS JOHN L Chief Executive Officer Option exercise · Employee Stock Option (right to buy) −1,777 54,421
2020-07-07 HIGGINS JOHN L Chief Executive Officer Option exercise · Employee Stock Option (right to buy) −1,373 93,627
2020-07-07 HIGGINS JOHN L Chief Executive Officer Option exercise · Employee Stock Option (right to buy) −1,165 54,226
2020-06-30 Berkman Charles S SVP, Gen. Counsel & Secretary Other acquisition +238 $89.03 $21K 41,115
2020-06-30 Korenberg Matthew E EVP,Finance & Strategy and CFO Other acquisition +238 $89.03 $21K 25,936
2020-06-10 Sabba Stephen L Director Grant or award +831 24,431
2020-06-10 Sabba Stephen L Director Grant or award · Non-Qualified Stock Option (right to buy) +2,468 2,468
2020-06-10 Aryeh Jason Director Grant or award +831 68,034
2020-06-10 Aryeh Jason Director Grant or award · Non-Qualified Stock Option (right to buy) +2,468 2,468

Page 38 of 43 · 858 trades